Not So Different: A Podcast from The Center for Biosimilars
Not So Different: a Podcast from The Center for Biosimilars
157 episodes
3 months ago
In this insightful podcast episode, host Giuseppe Randazzo, senior vice president of sciences and regulatory affairs at the Association for Accessible Medicines (AAM), welcomes former Sandoz executive and biosimilar expert Hillel Cohen to discuss the evolving world of biosimilars. The conversation covers the scientific and regulatory landscape, touching on the progress in streamlining biosimilar development, the importance of following scientific advancements, and the potential for harmonization in global health regulations.
All content for Not So Different: A Podcast from The Center for Biosimilars is the property of Not So Different: a Podcast from The Center for Biosimilars and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this insightful podcast episode, host Giuseppe Randazzo, senior vice president of sciences and regulatory affairs at the Association for Accessible Medicines (AAM), welcomes former Sandoz executive and biosimilar expert Hillel Cohen to discuss the evolving world of biosimilars. The conversation covers the scientific and regulatory landscape, touching on the progress in streamlining biosimilar development, the importance of following scientific advancements, and the potential for harmonization in global health regulations.
S6 Ep30: Insights from Festival of Biologics: Dracey Poore Discusses Cardinal Health’s 2024 Biosimilar Report
Not So Different: A Podcast from The Center for Biosimilars
14 minutes
1 year ago
S6 Ep30: Insights from Festival of Biologics: Dracey Poore Discusses Cardinal Health’s 2024 Biosimilar Report
In April, The Center for Biosimilars had the pleasure of attending Festival of Biologics USA in San Diego, California, where we got to cover major presentations and discuss the global biosimilar industry with valued experts in the space. One of those experts is joining us today to discuss takeaways from the meeting: Dracey Poore, director of biosimilars at Cardinal Health, who presented on market insights that came out of Cardinal Health's annual biosimilar report.
Prior to her work with Cardinal Health, Dracey worked for Organon and Merck as associate director of US oncology biosimilar marketing strategy. The Cardinal Health biosimilar report is a hotly anticipated report for the industry, presenting on how the market is developing as well as evolving prescriber trends and perspectives on these medications. We are pleased to have Dracey for her first guest appearance on Not So Different!
Not So Different: A Podcast from The Center for Biosimilars
In this insightful podcast episode, host Giuseppe Randazzo, senior vice president of sciences and regulatory affairs at the Association for Accessible Medicines (AAM), welcomes former Sandoz executive and biosimilar expert Hillel Cohen to discuss the evolving world of biosimilars. The conversation covers the scientific and regulatory landscape, touching on the progress in streamlining biosimilar development, the importance of following scientific advancements, and the potential for harmonization in global health regulations.
